| Dr Oleg Epelbaum, MD | |
|
100 Woods Rd, Valhalla, NY 10595-1530 | |
| (914) 493-6616 | |
| (914) 493-5827 |
| Full Name | Dr Oleg Epelbaum |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 20 Years |
| Location | 100 Woods Rd, Valhalla, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598923500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 238019 (New York) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 238019 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westchester Medical Center | Valhalla, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Westchester Medical Center Advanced Physician Services Pc | 3173660776 | 729 |
News Archive
Inviragen, a company developing vaccines to protect against infectious diseases worldwide, and the Program for the Study and Control of Tropical Diseases (PECET), jointly announced the initiation of a Phase 1 clinical trial of DENVax™ in Colombia. DENVax is an investigational vaccine designed to provide protection against all four dengue virus serotypes. The trial will measure the safety of DENVax as well as the immune responses induced by the vaccine in healthy adults in Rionegro, Colombia.
Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific (NYSE: BSX), has reported two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the Taxus(R) Express(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
MeadWestvaco Corp. announced today the availability of its Preservative Free Pump Topical for sampling. This product, specifically engineered for topical applications, is the most recent innovation in its portfolio of preservative free pharmaceutical spray pumps. The new pump will be featured at Pharmapack 2011, in Paris, France from February 23-24.
› Verified 1 days ago
| Entity Name | Northwell Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215019500 PECOS PAC ID: 3971531039 Enrollment ID: O20070215000718 |
News Archive
Inviragen, a company developing vaccines to protect against infectious diseases worldwide, and the Program for the Study and Control of Tropical Diseases (PECET), jointly announced the initiation of a Phase 1 clinical trial of DENVax™ in Colombia. DENVax is an investigational vaccine designed to provide protection against all four dengue virus serotypes. The trial will measure the safety of DENVax as well as the immune responses induced by the vaccine in healthy adults in Rionegro, Colombia.
Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific (NYSE: BSX), has reported two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the Taxus(R) Express(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
MeadWestvaco Corp. announced today the availability of its Preservative Free Pump Topical for sampling. This product, specifically engineered for topical applications, is the most recent innovation in its portfolio of preservative free pharmaceutical spray pumps. The new pump will be featured at Pharmapack 2011, in Paris, France from February 23-24.
› Verified 1 days ago
| Entity Name | Westchester Medical Center Advanced Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912131392 PECOS PAC ID: 3173660776 Enrollment ID: O20091031000042 |
News Archive
Inviragen, a company developing vaccines to protect against infectious diseases worldwide, and the Program for the Study and Control of Tropical Diseases (PECET), jointly announced the initiation of a Phase 1 clinical trial of DENVax™ in Colombia. DENVax is an investigational vaccine designed to provide protection against all four dengue virus serotypes. The trial will measure the safety of DENVax as well as the immune responses induced by the vaccine in healthy adults in Rionegro, Colombia.
Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific (NYSE: BSX), has reported two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the Taxus(R) Express(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
MeadWestvaco Corp. announced today the availability of its Preservative Free Pump Topical for sampling. This product, specifically engineered for topical applications, is the most recent innovation in its portfolio of preservative free pharmaceutical spray pumps. The new pump will be featured at Pharmapack 2011, in Paris, France from February 23-24.
› Verified 1 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609120674 PECOS PAC ID: 8224282926 Enrollment ID: O20130205000439 |
News Archive
Inviragen, a company developing vaccines to protect against infectious diseases worldwide, and the Program for the Study and Control of Tropical Diseases (PECET), jointly announced the initiation of a Phase 1 clinical trial of DENVax™ in Colombia. DENVax is an investigational vaccine designed to provide protection against all four dengue virus serotypes. The trial will measure the safety of DENVax as well as the immune responses induced by the vaccine in healthy adults in Rionegro, Colombia.
Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific (NYSE: BSX), has reported two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the Taxus(R) Express(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
MeadWestvaco Corp. announced today the availability of its Preservative Free Pump Topical for sampling. This product, specifically engineered for topical applications, is the most recent innovation in its portfolio of preservative free pharmaceutical spray pumps. The new pump will be featured at Pharmapack 2011, in Paris, France from February 23-24.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Oleg Epelbaum, MD 19 Bradhurst Ave, Suite 3100n, Hawthorne, NY 10532-2140 Ph: (914) 909-9018 | Dr Oleg Epelbaum, MD 100 Woods Rd, Valhalla, NY 10595-1530 Ph: (914) 493-6616 |
News Archive
Inviragen, a company developing vaccines to protect against infectious diseases worldwide, and the Program for the Study and Control of Tropical Diseases (PECET), jointly announced the initiation of a Phase 1 clinical trial of DENVax™ in Colombia. DENVax is an investigational vaccine designed to provide protection against all four dengue virus serotypes. The trial will measure the safety of DENVax as well as the immune responses induced by the vaccine in healthy adults in Rionegro, Colombia.
Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific (NYSE: BSX), has reported two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the Taxus(R) Express(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
MeadWestvaco Corp. announced today the availability of its Preservative Free Pump Topical for sampling. This product, specifically engineered for topical applications, is the most recent innovation in its portfolio of preservative free pharmaceutical spray pumps. The new pump will be featured at Pharmapack 2011, in Paris, France from February 23-24.
› Verified 1 days ago
Radhika Voleti, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 | |
Thai Quoc Nguyen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 347-944-4364 | |
Fareena Nawaz, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 | |
Dr. Steven Silverman, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 401 Columbus Ave, Valhalla, NY 10595 Phone: 914-769-0268 Fax: 914-769-6303 | |
Ms. Dana Rachel Berg, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-533-4111 | |
Dr. Leanne Michelle Forman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Westchester Medical Center, Grasslands Road, Cedarwood Hall Occupational Health, Valhalla, NY 10595 Phone: 914-493-5140 Fax: 914-493-7359 | |
Chinwe Chibundo Anekwe, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-6612 Fax: 914-493-6708 |